60 metagenomic sequencing data from PD patients

Key Points

• The aim is to analyze gut microbiome differences between Parkinson's disease patients and healthy controls.
• Collected gut microbiome sequencing data from 60 participants.
• Included 30 Parkinson's disease patients and 30 healthy controls.
• Provides comparative microbiome profiles between the two groups.

Abstract